[The role of the hospital pharmacist in the prevention, treatment and management of the side effects associated with antiretroviral treatment]

Farm Hosp. 2010 Sep-Oct;34(5):237-50. doi: 10.1016/j.farma.2010.01.012. Epub 2010 Jul 23.
[Article in Spanish]

Abstract

At present, the side effects associated with antiretroviral treatment are the main reasons for discontinuation of this kind of therapy, both in clinical trials and in regular clinical practise. On the other hand, due to the change of direction that our profession has suffered in recent years, we face the need to establish a different relationship with the patient, achieving direct and effective Pharmaceutical Care within a framework of shared responsibility for therapeutic results. Pharmacist interventions should be aimed at improving the quality of life of patients, which can only be achieved with a multidisciplinary approach and individualised and adjusted to new patterns of toxicity of the drugs currently used. The pharmacist who does this work must know how to interpret these side effects, giving accurate information to the patient about both pharmacological and non-pharmacological treatment and correct pharmaceutical follow-up which clearly sets forth the criteria for referral to medical appointments. The aim of this paper is to establish baselines so that the hospital pharmacist can perform clearly and uniformly in the prevention, identification and management of major side effects: gastrointestinal, cardiovascular, dermatological, at the central nervous system and kidney level, associated with antiretroviral therapy.

Publication types

  • English Abstract

MeSH terms

  • Anti-Retroviral Agents / adverse effects*
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Drug-Related Side Effects and Adverse Reactions / prevention & control
  • Drug-Related Side Effects and Adverse Reactions / therapy*
  • Humans
  • Pharmacists*
  • Pharmacy Service, Hospital
  • Practice Guidelines as Topic
  • Professional Role*

Substances

  • Anti-Retroviral Agents